文献速递腹部技术与安全US

直接抗病毒药物治疗丙型肝炎成功后剪切波弹性成像降低而剪切波频散未降低

Reduction of Shear Wave Elastography but Not Shear Wave Dispersion After Successful Hepatitis C Treatment With Direct-Acting Antiviral Agents.
PubMed 文献 · J Ultrasound Med · 2020-12-07

回顾性分析122例接受直接抗病毒药物治疗的慢性丙型肝炎患者,治疗前及停药后12周行二维剪切波弹性成像、剪切波频散、衰减成像、瞬态弹性成像及受控衰减参数检查。治疗后二维剪切波弹性成像和瞬态弹性成像测值降低,受控衰减参数升高,剪切波频散和衰减成像无统计学显著变化。

要点

  • 直接抗病毒药物治疗后二维剪切波弹性成像和瞬态弹性成像测值降低,剪切波频散和衰减成像无显著变化。
  • 受控衰减参数在治疗后升高。
  • 二维剪切波弹性成像与瞬态弹性成像强相关(r=0.885-0.897;P<.001)。

核心结论

  • 直接抗病毒药物治疗可显著降低丙型肝炎患者的肝脏硬度(二维剪切波弹性成像和瞬态弹性成像测值均降低),但不降低剪切波频散和衰减成像值;治疗后受控衰减参数升高。

研究设计与样本

  • 回顾性研究,纳入2017年1月至2020年6月接受直接抗病毒药物治疗的慢性丙型肝炎患者122例,中位年龄61岁,于治疗前及停药后12周记录二维剪切波弹性成像、剪切波频散、衰减成像、瞬态弹性成像及受控衰减参数结果。

诊断标准与关键数值

  • 121例(99.2%)在直接抗病毒药物治疗后12周达到持续病毒学应答;纤维化4指数、天冬氨酸氨基转移酶与血小板比值指数、二维剪切波弹性成像及瞬态弹性成像测值在治疗后降低;受控衰减参数升高;剪切波频散和衰减成像无统计学显著变化;二维剪切波弹性成像与瞬态弹性成像强相关(r=0.885-0.897;P<.001)。
  • 白蛋白和基线肝脏硬度测值是直接抗病毒药物治疗后肝脏硬度测值变化的独立因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Successful antiviral treatment in patients with hepatitis C can lead to reduced liver stiffness. In this study, we attempted to compare 2-dimensional (2D) shear wave elastography (SWE), shear wave dispersion (SWD), and attenuation imaging (ATI) with transient elastography (TE) and the controlled attenuation parameter (CAP) in patients under direct-acting antiviral (DAA) therapy.

METHODS: Patients with chronic hepatitis C infection undergoing DAA therapy from January 2017 to June 2020 were retrospectively examined. The results of 2D SWE, SWD, ATI, TE, and CAP were recorded before and 12 weeks after the completion of DAA therapy.

RESULTS: A total of 122 patients with a median age of 61 years were investigated; among them, 121 (99.2%) achieved a sustained virologic response at 12 weeks after DAA therapy. Fibrosis 4, the aspartate aminotransferase-to-platelet ratio index, 2D SWE, and TE were reduced after DAA therapy. The CAP was increased; however, SWD and ATI showed no statistically significant changes after DAA therapy. Two-dimensional SWE and TE were strongly correlated (r = 0.885-0.897; P < .001). Albumin and the baseline liver stiffness measurement were independent factors of liver stiffness measurement changes after DAA therapy.

CONCLUSIONS: Direct-acting antiviral therapy can significantly decrease liver stiffness (using both 2D SWE and TE) but not SWD and ATI values in patients with hepatitis C. An increased CAP is also observed after DAA therapy.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Su PY, Su WW, Wu LS, et al. Reduction of Shear Wave Elastography but Not Shear Wave Dispersion After Successful Hepatitis C Treatment With Direct-Acting Antiviral Agents. J Ultrasound Med. 2020. PMID: 33400288. doi:10.1002/jum.15576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。